In 2014, two years after her Nobel Prize-winning invention of
Read moreFDA approves first test of CRISPR to correct genetic defect causing sickle cell disease
FDA Approves New Indication & New Product Formulation for Myrbetriq for Use in Children with Neurogenic Detrusor Overactivity (NDO)
TOKYO, March 26, 2021 /PRNewswire/ — Astellas Pharma Inc. (TSE:
Read moreFDA Approves Kimyrsa
FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients
Read moreBiden’s Criticism of Trump Team’s Vaccine Contracts Is a Stretch
Editor’s note: Find the latest COVID-19 news and guidance in
Read moreU.S. FDA Approves Yescarta for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
SANTA MONICA, Calif.–(BUSINESS WIRE)–Mar. 5, 2021– Kite, a Gilead Company (Nasdaq: GILD),
Read moreFDA: Recall of Medtronic HVAD Implant Kits Is Class 1
A recall of implant kits for the HeartWare Ventricular Assist
Read moreFDA Authorizes First OTC COVID-19 Home Test Collection Kit
THURSDAY, Dec. 10, 2020 — The U.S. Food and Drug
Read moreFDA panel reviews 1st new Alzheimer’s drug in 2 decades
One of the biggest drug decisions in decades is looming
Read moreFDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
FRIDAY, Oct. 23, 2020 — At a meeting of the
Read moreHorizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for Procysbi (Cysteamine Bitartrate) Delayed-Release Oral Granules
DUBLIN–(BUSINESS WIRE)–February 18, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP)
Read more